Medical News

RSS

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc., will provide an update on the status of the Company's therapeutic and preventative HIV vaccines at the 2011 World Vaccine Conference at the Gaylord National Hotel and Convention Center in Washington DC on Thursday, April 14.

8 Apr 2011

NCAJ launches new Web site to inform North Carolinians about workers comp bill

The North Carolina Advocates for Justice has launched a new Web site to inform North Carolinians about potential legislation that will restrict their rights if injured on the job.

8 Apr 2011

House Panel approves Ryan 2012 budget blueprint on party-line vote

The GOP budget proposal's Medicare provisions continue to draw scrutiny and debate about what the program's future should look like, how the plan would change senior citizens' health care costs and what its political implications might be.

8 Apr 2011

First trial to test shared decision making for weight-loss surgery

A video-based decision aid helped severely obese people to make more informed choices about bariatric surgery and reach more certainty about them, according to a trial involving 152 Group Health patients, e-published in Obesity in advance of print. This randomized controlled trial is the first to test shared decision making for weight-loss surgery.

8 Apr 2011

Conifer to present 'how to implement clinical denials management strategy' at NICM/ACMA

Conifer Health Solutions, a leader in revenue cycle and business process solutions for healthcare providers, announced the company will present "How to Implement an Effective Clinical Denials Management Strategy" at the 2011 NICM/ACMA Case Management conference on Saturday, April 9, at 12:15 p.m. EDT. The conference will be held at the World Marriot Hotel in Orlando, Fla.

8 Apr 2011

ASBMB to honor 11 scientists with annual awards for biomedical research

The winners of the American Society for Biochemistry and Molecular Biology annual awards will give lectures at the Experimental Biology 2011 conference April 9-13 at the Walter E. Washington Convention Center in Washington, D.C.

8 Apr 2011

New Clinical Practice Guideline for evaluation and treatment of pituitary incidentalomas

Today, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

8 Apr 2011

Hospira focuses on clinical surveillance systems to help reduce antimicrobial resistance

As part of World Health Day 2011, the World Health Organization is calling on policy makers, providers, the public and the healthcare industry to take action to combat the serious health threat of antimicrobial resistance.

8 Apr 2011

IDSI receives FDA additional information request regarding CTLM imaging device 510(k) application

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that it has received notification from the Food and Drug Administration ( FDA) requesting additional information of its 510 (k) application in order to complete their review.

8 Apr 2011

GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS

On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.

8 Apr 2011

Long-term delivery of CNTF slows loss of visual acuity caused by geographic atrophy

A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.

8 Apr 2011

Bayer, Regeneron initiate two VEGF Trap-Eye Phase 3 trials in Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.

8 Apr 2011

Bruker receives Health Canada approval for IVD MALDI Biotyper

At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.

8 Apr 2011

Scientists discover unknown function of dopamine in brain

A study of the salamander brain has led researchers at Karolinska Institutet to discover a hitherto unknown function of the neurotransmitter dopamine. In an article published in the scientific journal Cell Stem Cell they show how in acting as a kind of switch for stem cells, dopamine controls the formation of new neurons in the adult brain. Their findings may one day contribute to new treatments for neurodegenerative diseases, such as Parkinson's.

8 Apr 2011

Though Congressional leaders cite progress, current-year spending deal still in play

If lawmakers fail to reach agreement on the 2011 budget, the government will shut down at 12:01 a.m. Saturday. Federal agencies have contingency plans in place in the event this happens. Media outlets report that Medicare and Medicaid would operate normally in the short run. Meanwhile, considerable discussion continues regarding what the political fallout will be and whether the public will hold Democrats or Republicans accountable.

8 Apr 2011

Antidepressant medication improves physical recovery from stroke

A University of Iowa study finds that patients treated with a short course of antidepressants after a stroke have significantly greater improvement in physical recovery than patients treated with a placebo. Moreover, the study is the first to demonstrate that this physical recovery continues to improve for at least nine months after the antidepressant medication is stopped.

8 Apr 2011

Targacept's TC-5619 Phase 2 trial data in schizophrenia presented at ICOSR

Targacept, Inc. today announced the presentation of data from a Phase 2 clinical proof of concept trial to assess TC-5619 as an augmentation therapy to improve cognition in patients with schizophrenia at the International Congress on Schizophrenia Research in Colorado Springs, Colorado.

8 Apr 2011

Refined carbohydrates create an ill and obese population

When it comes to feeding a body well, we've all been told we need proteins, fats and carbohydrates. For years, many of those we trust for health information have told us that the foundation of our diet should primarily consist of carbohydrates, namely, grains, breads and pastas.

8 Apr 2011

House subcommittee plans hearings on ACOs

In related news, Politico Pro reports that five leading health systems announced a plan to partner in sharing electronic health records. These systems note that the ability to share patient data with EHRs is key to success in creating ACOs.

8 Apr 2011

Male abuse victims more likely to suffer from psychological trauma

Men who are abused by their female partners can suffer significant psychological trauma, such as post-traumatic stress disorder, depression and suicidal thoughts, according to two new papers published by the American Psychological Association.

8 Apr 2011

Medical News

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

NCAJ launches new Web site to inform North Carolinians about workers comp bill

House Panel approves Ryan 2012 budget blueprint on party-line vote

First trial to test shared decision making for weight-loss surgery

Conifer to present 'how to implement clinical denials management strategy' at NICM/ACMA

ASBMB to honor 11 scientists with annual awards for biomedical research

New Clinical Practice Guideline for evaluation and treatment of pituitary incidentalomas

Hospira focuses on clinical surveillance systems to help reduce antimicrobial resistance

IDSI receives FDA additional information request regarding CTLM imaging device 510(k) application

GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS

Long-term delivery of CNTF slows loss of visual acuity caused by geographic atrophy

Bayer, Regeneron initiate two VEGF Trap-Eye Phase 3 trials in Diabetic Macular Edema

Bruker receives Health Canada approval for IVD MALDI Biotyper

Scientists discover unknown function of dopamine in brain

Though Congressional leaders cite progress, current-year spending deal still in play

Antidepressant medication improves physical recovery from stroke

Targacept's TC-5619 Phase 2 trial data in schizophrenia presented at ICOSR

Refined carbohydrates create an ill and obese population

House subcommittee plans hearings on ACOs

Male abuse victims more likely to suffer from psychological trauma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News